Dr. Lal Path Labs Ltd. has informed the Exchange about Schedule of meet
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has disclosed its upcoming schedule of meetings with analysts and institutional investors, as required under SEBI listing rules. Three meetings are planned: one with Mirae Asset Securities in South Korea on September 5, 2025, one with UBS Securities in Gurugram on September 10, 2025, and the Kotak Healthcare Forum 2025 in Mumbai on September 19, 2025. The company has clarified that no unpublished price-sensitive information (UPSI) will be shared during these meetings. The filing is a routine compliance disclosure signed by Company Secretary Vinay Gujral. Dates are subject to change based on exigencies.
This is a routine regulatory disclosure with no new business or financial information, so it is unlikely to cause any immediate stock price movement. It signals that the company is actively engaging with domestic and global investors, which can help improve visibility and analyst coverage over time.